We are an industry-leading manager of ILS capital, serving the needs of large institutional investors by bringing RenaissanceRe’s reputation for superior risk selection and portfolio construction to our insurance-linked strategies. Our unique hybrid model of owned and managed capital provides broad access to risk, specialized underwriting, and strong governance and ensures our interests are aligned with those of our investors.
More than two decades ago, RenaissanceRe Capital Partners pioneered the matching of attractive insurance-linked risk with partner capital. Since then, we have expanded our offerings to encompass RenaissanceRe’s Property and Casualty & Specialty underwriting portfolio, providing our investors with access to the broad range of uncorrelated asset classes that they seek when constructing their portfolios.
RenaissanceRe Capital Partners delivers a differentiated model focusing on long-term partnerships, excellent service and bringing high-quality capacity to the market.
(1)September 30, 2022.
(2)Partner capital includes RenaissanceRe’s co-investment and ownership in DaVinci, Fontana, Medici, Top Layer and Upsilon, as well as third-party capital in DaVinci (plus debt), Fontana, Medici, Top Layer, Upsilon and Vermeer. Figures reflected as follows: DaVinci common shareholders’ equity and debt; Top Layer’s equity capital supported by a $75M credit facility plus $3.9 billion stop loss reinsurance provided by State Farm; Vermeer common shareholders’ equity; Upsilon and Medici as total capital invested in non-voting participating shares; and Fontana limited partners’ capital. Information as of September 30, 2022.
(3)Source: Trading Risk: ILS Investor Guide, H1 2022. Based on third-party capital, not including RenaissanceRe’s co-investment. Adjustments to source figures for RenaissanceRe include addition of $4 billion related to Top Layer and reduction of $780 million related to Langhorne, a vehicle targeting large in-force life and annuity blocks.
Our Key Differentiators
Access to Risk
Alignment of Interest
All information as of June 30, 2022, unless otherwise stated.